Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2025 Mar;27(2):257-260.
doi: 10.1007/s40272-024-00678-y. Epub 2025 Jan 8.

Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?

Affiliations
Comment

Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?

Christian A Maiwald et al. Paediatr Drugs. 2025 Mar.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: This project was not funded. Conflict of interest: C. A. Maiwald has a financial relationship in the profits of the Neofact® product as inventor (Murrplastik Medizintechnik GmbH, Germany) and his research projects on LISA are, in part, supported by Lyomark Pharma GmbH, Germany. Karel Allegaert is an Editorial Board member of Pediatric Drugs. Karel Allegaert was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Patient consent for publication: Not applicable. Ethics approval: Not applicable. Availability of data and materials: Not applicable. Consent to participate: Not applicable. Code availability: Not applicable. Author contributions: CAM and KA drafted the first version of the manuscript in cooperation and both made important contributions from their research perspective. Both reviewed and approved the final version of the manuscript.

Comment on

Similar articles

References

    1. Nissimov S, Kohn A, Keidar R, Livne A, Shemer M, Gover A, et al. Dexmedetomidine for less invasive surfactant administration: a pilot study. Paediatr Drugs. 2024. https://doi.org/10.1007/s40272-024-00667-1 . - DOI - PubMed
    1. Stark A, Smith PB, Hornik CP, Zimmerman KO, Hornik CD, Pradeep S, et al. Medication use in the neonatal Intensive Care Unit and changes from 2010 to 2018. J Pediatr. 2022;240:66-71.e4. - DOI - PubMed
    1. Breindahl N, Tolsgaard MG, Henriksen TB, Roehr CC, Szczapa T, Gagliardi L, et al. Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study. Pediatr Res. 2023;94(3):1216–24. - DOI - PubMed - PMC
    1. Maiwald CA, Franz AR, Poets CF, Springer L. Less invasive surfactant administration in preterm infants in tertiary neonatal intensive care units in Germany: a survey. Neonatology. 2024:1–10. https://doi.org/10.1159/000539302 . PMID 39019018.
    1. Klotz D, Porcaro U, Fleck T, Fuchs H. European perspective on less invasive surfactant administration—a survey. Eur J Pediatr. 2017;176(2):147–54. - DOI - PubMed

LinkOut - more resources